. 1976 Apr;26(4):477-8.

Mode of action of isoniazide (INH). Short communication: isolation and identification of an analog of NAD from 3H-INH-treated bacterial cells

J K Seydel et al. Arzneimittelforschung. 1976 Apr.

. 1976 Apr;26(4):477-8.

No abstract available

Similar articles

[NAD(P)-glycohydrolase in tuberculosis bacteria. A contribution to the mechanism of action INH].
Bartmann K, Coper H, Jütte R. Bartmann K, et al. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1967;257(1):8. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1967. PMID: 4385332 German. No abstract available.
Crystallographic studies on the binding of isonicotinyl-NAD adduct to wild-type and isoniazid resistant 2-trans-enoyl-ACP (CoA) reductase from Mycobacterium tuberculosis.
Dias MV, Vasconcelos IB, Prado AM, Fadel V, Basso LA, de Azevedo WF Jr, Santos DS. Dias MV, et al. J Struct Biol. 2007 Sep;159(3):369-80. doi: 10.1016/j.jsb.2007.04.009. Epub 2007 May 3. J Struct Biol. 2007. PMID: 17588773
[The mechanism of action of isoniazid. A chemical model of activation].
Bernadou J, Nguyen M, Meunier B. Bernadou J, et al. Ann Pharm Fr. 2001 Sep;59(5):331-7. Ann Pharm Fr. 2001. PMID: 11787427 French.
Mechanisms of action of isoniazid.
Timmins GS, Deretic V. Timmins GS, et al. Mol Microbiol. 2006 Dec;62(5):1220-7. doi: 10.1111/j.1365-2958.2006.05467.x. Epub 2006 Oct 27. Mol Microbiol. 2006. PMID: 17074073 Review.
A review of the action of isoniazid.
Youatt J. Youatt J. Am Rev Respir Dis. 1969 May;99(5):729-49. doi: 10.1164/arrd.1969.99.5.729. Am Rev Respir Dis. 1969. PMID: 4306211 Review. No abstract available.

Isoniazid interaction with tyrosine as a possible mode of action of the drug in mycobacteria.
Herman RP, Weber MM. Herman RP, et al. Antimicrob Agents Chemother. 1980 Feb;17(2):170-8. doi: 10.1128/AAC.17.2.170. Antimicrob Agents Chemother. 1980. PMID: 7387139 Free PMC article.
Antimycobacterial susceptibility evaluation of rifampicin and isoniazid benz-hydrazone in biodegradable polymeric nanoparticles against Mycobacterium tuberculosis H37Rv strain.
Hakkimane SS, Shenoy VP, Gaonkar SL, Bairy I, Guru BR. Hakkimane SS, et al. Int J Nanomedicine. 2018 Jul 23;13:4303-4318. doi: 10.2147/IJN.S163925. eCollection 2018. Int J Nanomedicine. 2018. PMID: 30087562 Free PMC article.